Regulation of the Mutually Exclusive Exons 8a and 8 in the CaV1.2 Calcium Channel Transcript by Polypyrimidine Tract-binding Protein
暂无分享,去创建一个
Douglas L. Black | D. Black | G. Chawla | J. Nikolic | Sika Zheng | Shalini Sharma | Sika Zheng | Geetanjali Chawla | Shalini Sharma | Zhen Zhi Tang | Julia Nikolic | Z. Tang
[1] R. Kole,et al. RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice , 2009, Proceedings of the National Academy of Sciences.
[2] D. Black,et al. Developmental Control of CaV1.2 L-Type Calcium Channel Splicing by Fox Proteins , 2009, Molecular and Cellular Biology.
[3] R. Breathnach,et al. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon , 1995, Molecular and cellular biology.
[4] H. Reuter,et al. Ca2+ channel sensitivity towards the blocker isradipine is affected by alternative splicing of the human α1C subunit gene , 1998, FEBS letters.
[5] D. Lipscombe,et al. Functional diversity in neuronal voltage-gated calcium channels by alternative splicing of Cavα1 , 2002, Molecular Neurobiology.
[6] Brenda F Baker,et al. Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon , 2007, PLoS biology.
[7] T. Soong,et al. CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency , 2010, Pflügers Archiv - European Journal of Physiology.
[8] Lili Wan,et al. RNA and Disease , 2009, Cell.
[9] Frank B Sachse,et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. McDonough. Calcium Channel Pharmacology , 2012, Springer US.
[11] P. Grabowski,et al. Mutations in RRM4 uncouple the splicing repression and RNA-binding activities of polypyrimidine tract binding protein. , 2002, RNA.
[12] R. Tsien,et al. The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels , 2008, Proceedings of the National Academy of Sciences.
[13] S. Priori,et al. CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism , 2004, Cell.
[14] T. Soong,et al. Signature combinatorial splicing profiles of rat cardiac- and smooth-muscle Cav1.2 channels with distinct biophysical properties. , 2007, Cell calcium.
[15] J. Striessnig. Pharmacology, Structure and Function of Cardiac L-Type Ca2+ Channels , 1999, Cellular Physiology and Biochemistry.
[16] Christopher W. J. Smith. Alternative Splicing— When Two’s a Crowd , 2005, Cell.
[17] Christopher W. J. Smith,et al. Novel modes of splicing repression by PTB. , 2006, Trends in biochemical sciences.
[18] N. Klugbauer,et al. Alternatively spliced IS6 segments of the alpha 1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. , 1997, Circulation research.
[19] D. Black,et al. Combinatorial control of a neuron-specific exon. , 1999, RNA.
[20] D. T. Yue,et al. Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. , 2005, Cardiovascular research.
[21] T. Werge,et al. CACNA1C (rs1006737) is associated with schizophrenia , 2010, Molecular Psychiatry.
[22] Mark E. Anderson,et al. Proarrhythmic Defects in Timothy Syndrome Require Calmodulin Kinase II , 2008, Circulation.
[23] William A Catterall,et al. Voltage-Gated Calcium Channels , 2011 .
[24] J. Lueck,et al. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. , 2007, The Journal of clinical investigation.
[25] Peer Bork,et al. Common exon duplication in animals and its role in alternative splicing. , 2002, Human molecular genetics.
[26] W. Catterall. Structure and regulation of voltage-gated Ca2+ channels. , 2000, Annual review of cell and developmental biology.
[27] N. Soldatov. Genomic structure of human L-type Ca2+ channel. , 1994, Genomics.
[28] R. Dolmetsch,et al. Signaling to the Nucleus by an L-type Calcium Channel-Calmodulin Complex Through the MAP Kinase Pathway , 2001, Science.
[29] W. Fairbrother,et al. Repressing the neuron within. , 2008, BioEssays : news and reviews in molecular, cellular and developmental biology.
[30] T. Soong,et al. Alternative splicing of voltage-gated calcium channels: from molecular biology to disease , 2009, Pflügers Archiv - European Journal of Physiology.
[31] Douglas L Black,et al. Exon repression by polypyrimidine tract binding protein. , 2005, RNA.
[32] Robert T. Schultz,et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.
[33] Guey-Shin Wang,et al. Splicing in disease: disruption of the splicing code and the decoding machinery , 2007, Nature Reviews Genetics.
[34] Christopher W. J. Smith,et al. Mutually exclusive splicing of α-tropomyosin exons enforced by an unusual lariat branch point location: Implications for constitutive splicing , 1989, Cell.
[35] G. van Ommen,et al. Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[36] Manuel A. R. Ferreira,et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.
[37] D. Black,et al. Cooperative Assembly of an hnRNP Complex Induced by a Tissue-Specific Homolog of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.
[38] L. Gangwani,et al. A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy , 2009, RNA biology.
[39] D. Black. Activation of c-src neuron-specific splicing by an unusual RNA element in vivo and in vitro , 1992, Cell.
[40] D. Lipscombe. Neuronal proteins custom designed by alternative splicing , 2005, Current Opinion in Neurobiology.
[41] D L Black,et al. A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon , 1997, Molecular and cellular biology.
[42] Christopher J. Lee,et al. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.
[43] Tohru Suzuki,et al. The Nonsense-mediated Decay Pathway and Mutually Exclusive Expression of Alternatively Spliced FGFR2IIIb and -IIIc mRNAs* , 2001, The Journal of Biological Chemistry.
[44] David Haussler,et al. Unusual Intron Conservation near Tissue-Regulated Exons Found by Splicing Microarrays , 2005, PLoS Comput. Biol..
[45] T. Maniatis,et al. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. , 2007, Molecular cell.
[46] K. Deisseroth,et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels , 1999, Nature.
[47] R. Sorek,et al. Intronic sequences flanking alternatively spliced exons are conserved between human and mouse. , 2003, Genome research.
[48] D. Abernethy,et al. Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets. , 2002, The Journal of pharmacology and experimental therapeutics.
[49] Johan T den Dunnen,et al. Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.
[50] D. Black,et al. Structure of PTB Bound to RNA: Specific Binding and Implications for Splicing Regulation , 2005, Science.
[51] L. Maquat,et al. Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells. , 2005, Current opinion in cell biology.
[52] Douglas L Black,et al. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. , 2007, Genes & development.
[53] P. Iversen,et al. Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[54] D. Black,et al. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. , 2007, Genes & development.
[55] Russ P. Carstens,et al. An Intronic Splicing Silencer Causes Skipping of the IIIb Exon of Fibroblast Growth Factor Receptor 2 through Involvement of Polypyrimidine Tract Binding Protein , 2000, Molecular and Cellular Biology.
[56] S. Stamm,et al. Alternative splicing and disease. , 2009, Biochimica et biophysica acta.
[57] C. Klee,et al. Calcium as a cellular regulator , 1999 .
[58] A. Koschak,et al. α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative Voltages* , 2001, The Journal of Biological Chemistry.
[59] A. J. Castiglioni,et al. Alternative Splicing in Voltage Gated Calcium Channels , 2004 .
[60] F. Lehmann-Horn,et al. The impact of splice isoforms on voltage‐gated calcium channel α1 subunits , 2004, The Journal of physiology.
[61] C. Smith,et al. Crossregulation and Functional Redundancy between the Splicing Regulator PTB and Its Paralogs nPTB and ROD1 , 2007, Molecular cell.
[62] Douglas L. Black,et al. Polypyrimidine tract binding protein blocks the 5' splice site-dependent assembly of U2AF and the prespliceosomal E complex. , 2005, Molecular cell.
[63] B. Rubin,et al. The Molecular Basis of Familial Dysautonomia: Overview, New Discoveries and Implications for Directed Therapies , 2007, NeuroMolecular Medicine.
[64] C. D. de Winter,et al. Therapeutic Modulation of DMD Splicing by Blocking Exonic Splicing Enhancer Sites with Antisense Oligonucleotides , 2006, Annals of the New York Academy of Sciences.
[65] N. Soldatov. Molecular diversity of L-type Ca2+ channel transcripts in human fibroblasts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[66] G. Lutz,et al. Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy , 2009, The Journal of Neuroscience.
[67] Adrian R Krainer,et al. Splicing therapeutics in SMN2 and APOB. , 2009, Current opinion in molecular therapeutics.
[68] Douglas L. Black,et al. Neuronal regulation of alternative pre-mRNA splicing , 2007, Nature Reviews Neuroscience.
[69] E. Blaskova,et al. Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological properties. , 2009, American journal of physiology. Heart and circulatory physiology.
[70] Dejie Yu,et al. Transcript Scanning Reveals Novel and Extensive Splice Variations in Human L-type Voltage-gated Calcium Channel, Cav1.2 α1 Subunit* , 2004, Journal of Biological Chemistry.
[71] T. Soong,et al. Differential splicing patterns of L-type calcium channel Cav1.2 subunit in hearts of Spontaneously Hypertensive Rats and Wistar Kyoto Rats. , 2008, Biochimica et biophysica acta.
[72] Tomaso Poggio,et al. Identification and analysis of alternative splicing events conserved in human and mouse. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[73] M. Wood,et al. RNA-targeted splice-correction therapy for neuromuscular disease. , 2010, Brain : a journal of neurology.